LifeTech Scientific Corporation (the “Company”) and its subsidiaries (the “Group”) announced the unaudited consolidated results for the six months ended 30 June 2020 (the “Reporting Period”)
30th March, 2020,LifeTech Scientific Corporation (the “Company”) and its subsidiaries (the “Group”) announced the audited consolidated results for the year ended 31 December 2019 (the “Reporting Period”)
LifeTech Scientific Corporation announced that it had entered into the Agreement with the wholly-owned subsidiary of China Everbright Limited, agreed to purchase, with funding to be provided by the Company, and the Vendor conditionally agreed to sell, an aggregate of not more than 300,000,000 shares, for the purpose of the Share Award Scheme.
On the afternoon of December 20, 2018, Jia Xingdong, Director of Shenzhen Municipal Commission of Economic Trade and Information Technology, and his delegation visited Lifetech for investigation
In 2018, Lifetech was approved to obtain two key national R&D program projects.
On December 5, 2018, Lifetech (1302.HK) was granted the 8th China Securities "Golden Bauhinia" Award for "Best Investor Relations Management Listed Companies". This award was obtained by Lifetech in three consecutive years.
Recently, sixteen members of the Thai-Chinese Culture & Economic Association and the Thai government and business delegation visited Lifetech. Mr. Xie Yuehui, Chairman and CEO of Lifetech was present at the reception ceremony.
Recently, Lifetech won the honor of "the most promising HKEx listed company" in the assessment for "Golden Wing Award" 2018 sponsored by the Securities Times.
Aug. 27, 2018-Hong Kong The minimally invasive cardiovascular interventional devices supplier Lifetech (the Company) and its subsidiaries (the Group) published their comprehensive results for the six months ending as at Jun. 30, 2018 (in the reporting period).
On Aug. 23, CCTV reports took Lifetech as an example to present how high-end medical device enterprises maintain their competitiveness through independent innovation and achieve rapid development under the support of national industry policies.